Predictive Value of Preoperative Quality-of-Life Measures

Surgical decision-making for intracranial malignancies requires clinicians to balance aggressive cytoreduction against the risk of functional decline. Traditional surgical assessments often rely on clinician-graded indices. However, recent evidence highlights that preoperative quality-of-life measures offer vital prognostic insights that standard metrics miss. When patients report their physical, emotional, and social well-being prior to craniotomy, these metrics directly correlate with post-operative high-value care outcomes. Therefore, integrating structured patient-reported outcome measures, such as the PROMIS-29 v2.0 survey, provides a standardized mechanism to quantify baseline vulnerability. In clinical cohorts of malignant intracranial tumors, including glioblastomas and brain metastases, baseline scores demonstrate significant predictive power. Specifically, self-reported physical function, pain interference, and mental health burdens correlate strongly with post-surgical recovery trajectories, hospital length of stay, and complication rates. Consequently, surgeons gain an objective, patient-centric window into perioperative physiological and psychological resilience. This paradigm shift ensures that surgical teams evaluate not only radiographic resectability but also holistic host factors. Ultimately, embedding patient perspectives into preoperative assessments empowers neurosurgical teams to personalize perioperative pathways, set realistic recovery expectations, and optimize resource utilization across the surgical continuum.

Evaluating PROMIS-29 Domains in Malignant Brain Tumors

The PROMIS-29 instrument evaluates seven core health domains alongside pain intensity. These domains include physical function, fatigue, pain interference, depression, anxiety and fear, social participation, and sleep disturbance. Malignant brain tumor patients frequently report substantial deviations from general population norms across these domains. In particular, baseline anxiety and fear scores are markedly elevated, reflecting the severe psychological burden of an intracranial malignancy diagnosis. Additionally, physical function impairment and pain interference serve as direct indicators of neuromotor compromise and systemic symptom load. When surgical teams assess these subscores individually, distinct patterns emerge that predict specific postoperative events. For example, lower baseline physical function scores independently predict an increased risk of extended hospital stays, delayed mobilization, and non-home discharge. Similarly, elevated baseline fatigue and pain interference closely correlate with higher postoperative analgesia requirements and prolonged rehabilitation needs. Furthermore, psychological distress scores highlight patients at elevated risk for perioperative delirium and poor treatment adherence. Thus, domain-level granularity moves beyond simple functional stratification. It offers neuro-oncologists and neurosurgeons actionable targets for early prehabilitation, psychosocial support, and targeted pain management protocols before surgical intervention begins.

Comparing PROMIS-29 with Traditional Surgical Risk Metrics

Historically, neurosurgeons have relied on clinician-administered tools such as the Karnofsky Performance Status, American Society of Anesthesiologists score, and the 5-factor modified Frailty Index. While these conventional scales provide valuable general risk estimates, they frequently suffer from inter-observer variability and fail to capture subjective patient burdens. In comparative analyses, patient-reported metrics consistently demonstrate superior discriminative ability for predicting adverse postoperative outcomes. Specifically, PROMIS-29 physical function subscores exhibit higher sensitivity and specificity than KPS or ASA physical status in forecasting non-routine discharge and prolonged recovery. Moreover, the modified Frailty Index, which focuses primarily on systemic medical comorbidities, often overlooks the rapid functional decline caused by focal intracranial disease. By contrast, patient-reported quality-of-life surveys capture both localized neurological disability and broader constitutional distress. Consequently, multivariate models that incorporate PROMIS-29 data demonstrate improved calibration and statistical power over traditional models. Therefore, modern surgical neuro-oncology must transcend reliance solely on clinician-graded scores. Incorporating patient-reported data creates a multidimensional risk profile. This comprehensive approach enhances pre-operative risk stratification, sharpens surgical selection criteria, and reduces unexpected postoperative complications.

Glioblastoma Versus Metastatic Lesions: Key Subgroup Nuances

Malignant intracranial tumors represent heterogeneous disease entities with differing systemic and neurological profiles. A critical clinical consideration involves comparing primary gliomas, such as glioblastoma, with secondary brain metastases. Patients presenting with metastatic brain lesions typically carry advanced systemic cancer burdens, previous chemotherapy toxicities, and distinct psychological stressors. As a result, metastatic cohorts frequently exhibit significantly higher baseline anxiety, fear, and fatigue compared to primary glioma cohorts. Conversely, glioblastoma patients often experience more localized neurocognitive deficits, focal motor deficits, and subtle personality alterations. Despite these distinct phenotypic presentations, preoperative physical function scores retain powerful predictive validity across both patient subgroups. In glioblastoma cases, low baseline functional scores emphasize the urgency of preserving eloquent cortical and subcortical pathways during cytoreduction. For metastatic disease, baseline functional limitations often guide decisions between open craniotomy, stereotactic radiosurgery, or palliative systemic therapies. Therefore, subgroup-specific PROM analysis provides neurosurgeons with crucial context. This granular approach ensures that surgical intervention aligns with the patient's overall oncologic prognosis and individual quality-of-life priorities.

Clinical Implications for High-Value Neurosurgical Care

Delivering high-value neurosurgical care requires maximizing clinical outcomes while optimizing healthcare expenditure and institutional resources. Unplanned readmissions, extended lengths of stay, and costly discharge dispositions significantly drive up neurosurgical episode costs. Preoperative quality-of-life screening enables clinicians to identify vulnerable patients prior to surgery, allowing for proactive resource allocation. For example, patients identified as high risk can receive immediate perioperative physical therapy consultations, early social work evaluations, and comprehensive discharge planning upon admission. In addition, recognizing severe preoperative anxiety and depressive symptoms allows teams to initiate behavioral health interventions before surgery. This targeted strategy mitigates perioperative distress and supports smoother convalescence. Furthermore, integrating PROMs into multidisciplinary tumor boards enhances shared decision-making. When surgical risks outweigh potential quality-of-life gains, clinicians and families can consider alternative palliative approaches or less invasive interventions. Consequently, high-value care models leverage patient-reported metrics to minimize avoidable surgical morbidities and reduce unnecessary healthcare expenditures.

Integrating PROMs into Routine Neurosurgical Practice

Implementing routine patient-reported outcome tracking in neurosurgical clinics requires thoughtful digital integration and streamlined clinical workflows. Electronic health records can automatically deploy digital surveys like the PROMIS-29 via patient portals prior to initial surgical consultation. As a result, clinicians receive real-time, objective scores directly within the clinical dashboard before meeting the patient. This digital automation minimizes administrative burden while ensuring consistent data collection across busy neuro-oncology clinics. Furthermore, clinical teams must establish standardized threshold scores to trigger prehabilitation protocols, nutritional support, and occupational therapy evaluations. In busy surgical practices, these objective cutoffs help triage resources effectively and eliminate subjective biases in surgical clearance. Additionally, longitudinal collection allows surgical teams to track post-operative functional recovery over time, identifying subtle clinical deterioration before acute readmission occurs. By standardizing PROM collection throughout the perioperative timeline, neurosurgical centers can elevate clinical quality, refine surgical indications, and foster truly patient-centered oncologic care.

How do preoperative quality-of-life measures improve neurosurgical planning?

Preoperative quality-of-life measures quantify baseline physical, emotional, and social functioning directly from the patient perspective. These scores identify physiological frailty and psychological distress early. Consequently, neurosurgeons can customize surgical goals, initiate targeted prehabilitation, optimize perioperative resources, and set realistic recovery expectations for high-risk patients.

Why does PROMIS-29 outperform traditional scores like KPS and ASA?

Unlike clinician-graded scales such as KPS and ASA, PROMIS-29 captures subjective functional limitations, fatigue, and emotional distress with high granularity. This granular, patient-reported assessment provides superior predictive sensitivity for post-operative outcomes, including hospital length of stay, non-routine discharge disposition, and perioperative complications in intracranial tumor surgery.

How can clinicians implement PROMIS-29 in routine neuro-oncology workflow?

Clinicians can embed PROMIS-29 into electronic health record patient portals, allowing automated survey completion before clinic visits. Automated scoring algorithms can instantly flag vulnerable patients. This streamlined workflow enables multidisciplinary teams to coordinate early rehabilitation, behavioral health interventions, and personalized surgical counseling without burdening daily clinic routines.

Disclaimer: This content is for informational and educational purposes only. It is not intended to provide medical advice, clinical diagnosis, or treatment recommendations. Clinical decisions should always be made by qualified healthcare professionals based on individual patient assessments and valid medical criteria. Refer to the latest local and national guidelines for clinical practice.

References

1. Khera A et al. Intracranial tumor preoperative patient-reported quality-of-life measures predict post-operative high-value care outcomes. Clin Neurol Neurosurg. 2026 Sep. doi: 10.1016/j.clineuro.2026.109511. PMID: 42208140.


2. Kole AJ et al. Physical Health-Related Quality of Life and Postsurgical Outcomes in Brain Tumor Resection Patients. World Neurosurg. 2022;164:e1002-e1010.


3. Galea GA et al. Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery. Cancers (Basel). 2023;15(18):4530.